The IFNAR2 gene helps cells receive type I interferon signals, which are part of the body’s early defense against viruses. If this gene does not work properly, the immune system may struggle to control some viral infections, and some people can become unusually ill after certain live virus vaccines. In medicine, this gene is important because rare pathogenic variants can cause an inherited immune condition, while other variants may slightly influence how severe an infection becomes. Public attention to IFNAR2 grew during the COVID-19 pandemic when studies linked it to severe illness risk.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how your body grows and works, and they can also influence how you react to food, stress, or medicines. For a deeper look at this subject, you can read more in the LearnHub.
Overview
IFNAR2Gene function
What if the gene works
The IFNAR2 gene helps cells respond to interferons, immune signals that warn of viral infection. This supports antiviral defenses and helps control inflammation.
Risk
What if the gene does not work
Severe variants in the IFNAR2 gene can weaken the body’s early antiviral defense, leading to unusually severe infections such as COVID-19, influenza, or reactions to some live vaccines. Milder variants may cause illness that appears later or is less severe.
Treatment
What does that mean for your treatment
With a loss-of-function variant in the IFNAR2 gene, no IFNAR2-specific treatment is currently established in guidelines. Because IFNAR2 is part of the receptor for type I interferon medicines, those drugs are generally not expected to help when receptor function is absent. The IFNAR2 gene is also being studied as a biomarker in viral illness, including COVID-19.
Conditions associated with IFNAR2
Gene function
What if the gene works
Your cells need fast warning signals when they meet a virus. The IFNAR2 gene helps them receive messages from type I interferons, a group of proteins that alert cells to infection. This keeps communication moving across many tissues and supports an organized early immune response.
This gene helps make part of a receptor on the cell surface that recognizes type I interferons. Together with a partner receptor piece called IFNAR1, it lets cells detect these immune warning signals and prepare to respond.
After interferons bind, the receptor made with help from the IFNAR2 gene passes the message from the cell surface to the cell's control center. This switches on sets of genes that guide protective cell behavior.
Signals through the receptor linked to the IFNAR2 gene help cells make proteins that slow viral growth and spread. This is one way the IFNAR2 gene helps the body respond to viral infections in a fast, coordinated way.
Type I interferon signals received through this pathway help nearby cells enter a more alert state during infection. They also support communication across the immune system, which helps defenses stay timely and better organized.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not cause any noticeable effects and simply represent natural genetic variation. At times, though, a variant can change gene function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IFNAR2 gene can reduce or abolish the receptor’s ability to reach the cell surface, bind type I interferons, or send the signal onward inside the cell. Milder missense variants may leave some signaling in place, while more disruptive truncating or splice variants can lead to little or no receptor activity. In people with two nonworking copies, this range helps explain how IFNAR2 gene variants affect interferon signaling and may influence how early or how strongly viral illness appears.
How variants are linked to conditions
Rare disease-causing variants in both copies of the IFNAR2 gene cause IFNAR2 deficiency, an inborn error of immunity (a genetic condition that affects the body's response to infections) linked to severe viral infections and severe reactions to some live attenuated vaccines, including MMR and yellow fever vaccine. Population studies have also linked some common IFNAR2 gene variants to a higher chance of critical COVID-19, but these risk associations do not make severe illness certain.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definitive diagnosis, particularly when several genes and environmental factors are involved. In certain cases, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific day-to-day factors that increase or reduce risk related to the IFNAR2 gene itself. Some changes in IFNAR2 have been linked with how the body handles certain viral infections, but personal risk still depends on the exact gene change and other health factors.
Inheritance of IFNAR2 variants
IFNAR2-related conditions are usually inherited in an autosomal recessive pattern. In practical terms, a child is affected when they inherit one nonworking copy of the IFNAR2 gene from each parent, while parents with one changed copy are typically carriers. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two working copies. This means IFNAR2 gene inheritance can affect sons and daughters equally.
What does my IFNAR2 result mean for my family?
For IFNAR2, the best-established inherited condition is passed down in a recessive way. In practical terms, close relatives may be carriers even if they are healthy, and brothers or sisters could also have the same condition. Family members’ chances depend on whether they inherited the same changed copy of the IFNAR2 gene.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the IFNAR2 gene, doctors use genetic testing for IFNAR2 variants on a blood or saliva sample. A lab reads the DNA sequence and compares it with the usual version of the gene, then reports whether a variant was found and how it is currently classified.
When should I consider getting a genetic test?
Genetic testing for the IFNAR2 gene may be worth considering when someone has repeated, unusually severe viral infections, especially after live vaccines, or a family history of a rare inherited problem with the body's antiviral defenses. In rare cases, it may also help explain life-threatening COVID-19 or influenza.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they explain depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small inherited differences can change how a drug is absorbed, broken down, transported, or how strongly it acts on its target. That helps explain why the same medication may work well for one person, seem less helpful for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medications. It examines links between genes and drugs to help explain why the same treatment can work differently in different people. For many medicines, genes influence either how powerfully a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. To look into this topic further, you can learn more in the LearnHub.
Drugs influenced by the IFNAR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so questions about symptoms, side effects, or treatment are best discussed with your doctor. Some research has looked at IFNAR2 and response to interferon-based treatments, but this is not used routinely in everyday care.
History
Researchers identified the IFNAR2 gene in the 1990s while working out how cells receive type I interferon signals, an important step in mapping the body’s antiviral response. Initially understood only through cell surface receptor studies, later recognized as tied to a specific gene, IFNAR2 became part of a broader effort to define the interferon receptor system. From these first observations, research expanded steadily and showed that the gene produces more than one receptor form through alternative splicing, meaning the body can make slightly different versions from the same gene. Interest in the IFNAR2 gene grew again during the COVID-19 pandemic, when large genetic studies linked some variants to differences in susceptibility to severe infection. These findings helped bring IFNAR2 into wider medical attention.